Leaflet EPIMAXAN 200mg film-coated tablets


Indicated for: epilepsy; migraine prevention

Route of administration: oral

Substance: topiramate (antiepileptic)

ATC: N03AX11 (Nervous system | Antiepileptics | Other antiepileptics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Teratogenic / fetal risk
Teratogenic / fetal risk

This medicine may affect fetal development.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Vision disturbances
Vision disturbances

This medicine may cause vision disturbances.

Topiramate is an antiepileptic drug used in the treatment of epilepsy and migraines. It works through multiple mechanisms, including blocking sodium channels, enhancing GABA (gamma-aminobutyric acid) activity, and inhibiting glutamate receptors, thereby reducing neuronal excitability.

Topiramate is administered orally, usually twice daily, with the dose gradually adjusted to minimize the risk of side effects. It is indicated both as monotherapy and as adjunctive therapy in controlling seizures and preventing migraines.

Common side effects include drowsiness, dizziness, weight loss, memory disturbances, and tingling sensations in the extremities. In rare cases, severe adverse reactions such as metabolic acidosis, glaucoma, or kidney stone formation may occur. Regular monitoring of the patient's condition is essential during treatment.

Topiramate is an effective and well-tolerated therapeutic option for managing epilepsy and migraines, contributing to improved quality of life for patients.

General data about EPIMAXAN 200mg

  • Substance: topiramate
  • Date of last drug list: 01-07-2013
  • Commercial code: W53134001
  • Concentration: 200mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for topiramate

Concentrations available for topiramate

  • 100mg
  • 15mg
  • 200mg
  • 25mg
  • 400mg
  • 50mg

Combinations with other substances